ScholarIQanswers from OpenAlex
Bon Secours Mercy Health
InstitutionResearch output, impact & collaborations
Bon Secours Mercy Health is a institution indexed in ScholarIQ from OpenAlex.
What is known about Bon Secours Mercy Health?
ScholarIQrecord summary
Bon Secours Mercy Health is a research organisation in Cincinnati, US. OpenAlex records 452 works and 11,189 citations for it. 233 researchers list it as their most recent affiliation.
How many works does Bon Secours Mercy Health have?
ScholarIQindexed works
Bon Secours Mercy Health has 452 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bon Secours Mercy Health have?
ScholarIQcitation count
Bon Secours Mercy Health has 11,189 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Bon Secours Mercy Health?
ScholarIQresearcher count
Bon Secours Mercy Health has 233 researchers in the ScholarIQ index.
What is the average h-index at Bon Secours Mercy Health?
ScholarIQavg h-index
Bon Secours Mercy Health has an average h-index of 98 in OpenAlex.
What is the ROR of Bon Secours Mercy Health?
ScholarIQror
The ROR for Bon Secours Mercy Health is on the source record.
What is the OpenAlex record for Bon Secours Mercy Health?
ScholarIQopenalex
The OpenAlex for Bon Secours Mercy Health is on the source record.
Who are the most-cited researchers behind Bon Secours Mercy Health?
ScholarIQtop researchers by citations
What are the most-cited papers on Bon Secours Mercy Health?
ScholarIQmost cited works
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreoné, G. Mazzella, Simone I. Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul J. Pockros, Jarosław Reguła, Ulrich Beuers, Michael Trauner, David Jones, Annarosa Floreani, Simon Hohenester, Velimir A. Luketic, Mitchell L. Shiffman, Karel J. van Erpecum, Vı́ctor Vargas, Catherine Vincent, Gideon M. Hirschfield, Hemant Shah, Bettina E. Hansen, Keith D. Lindor, Hanns–Ulrich Marschall, Kris V. Kowdley, Roya Hooshmand-Rad, Tonya Marmon, Shawn Sheeron, Richard Pencek, Leigh MacConell, Mark Pruzanski, Д. А. Шапиро
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones, Pol Boudes, Mark G. Swain, Christopher L. Bowlus, Michael Galambos, Bruce R. Bacon, Yvonne Döerffel, Norman Gitlin, Stuart C. Gordon, Joseph A. Odin, David Sheridan, M A Wörns, Virginia Clark, Linsey Corless, Heinz Hartmann, Mark Jonas, Andreas E. Kremer, George Mells, Peter Buggisch, B. Freilich, Cynthia Levy, John M. Vierling, David Bernstein, Marek Hartleb, Ewa Janczewska, Fedja A. Rochling, Hemant Shah, Mitchell L. Shiffman, John H. Smith, Yun‐Jung Choi, Alexandra Steinberg, Mónika Varga, Harinder Chera, Robert L. Martin, Charles A. McWherter, Gideon M. Hirschfield
How much of the research on Bon Secours Mercy Health is open access?
ScholarIQopen access share
50%OPEN ACCESS